期刊文献+

冠心病患者脉搏波速度相关因素探讨 被引量:2

Investigation on relationship between pulse wave velocity and coronary artery disease
下载PDF
导出
摘要 目的探讨冠心病患者脉搏波速度(PWV)变化特点及其相关危险因素。方法选取心血管内科住院疑诊冠心病患者59例,根据冠状动脉造影结果分为冠心病组(34例)和非冠心病组(25例),详细收集每例患者相关临床资料,包括患者年龄、性别、血压、心率、左室射血分数(LVEF)、血脂、空腹及餐后2 h血糖等结果。对所有入选者检测臂踝脉搏波速度(baPWV)。结果冠心病组与非冠心病组间baPWV[(1 945.29±251.57)cm/s vs(1 481.76±267.98)cm/s,P<0.01]、TC[(5.31±1.86)mmol/L vs(4.49±0.77)mmol/L,P<0.05]、LDL-C[(2.69±1.09)mmol/L vs(2.20±0.55)mmol/L,P<0.05]、血尿酸(UA)[(388.59±82.60)mmol/L vs(317.24±69.50)mmol/L,P<0.01]及超敏C-反应蛋白(hs-CRP)[(0.69±0.32)vs(0.09±0.52),P<0.01]差异有统计学意义,而其他指标两组间差异无统计学意义(P>0.05)。结论 baPWV与冠心病密切相关,且LDL-C、UA及hs-CRP在冠心病发生、发展中起重要作用。 Objective To investigate the relationship between brachial-ankle pulse wave velocity(baPWV) and coronary artery disease.Methods According to the results of coronary angiography,59 patients were divided into two groups.34 patients had history of coronary heart disease and 25 patients had no coronary heart disease.baPWV was measured,relevant clinical data and blood biochemistry test were collected.Results There were significant differences in baPWV[(1 945.29±251.57)cm/s vs(1 481.76±267.98)cm/s,P0.01],TC[(5.31±1.86)mmol/L vs(4.49±0.77)mmol/L,P0.05],LDL-C[(2.69±1.09)mmol/L vs(2.20±0.55) mmol/L,P0.05],UA[(388.59±82.60) mmol/L vs(317.24±69.50) mmol/L,P0.01] and hs-CRP[(0.69±0.32) vs(0.09±0.52),P0.01].But there were no significant differences in other clinical data.Conclusion There is close relationship between baPWV and coronary heart disease.LDL-C,UA and hs-CRP play an important role in the occurrence and development of coronary heart disease.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第9期862-863,866,共3页 Chongqing medicine
关键词 冠心病 尿酸 C-反应蛋白质 低密度脂蛋白胆固醇 脉搏波速度 coronary disease uric acid C-reactive proteins LDL-C baPWV
  • 相关文献

参考文献15

  • 1Lehmann ED. Clinical value of aortic pulse wave velocity measurement[J]. Lancet, 1999,354 (9178):528-529.
  • 2Asmar R,Benetos A, Topouchian J,et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies [J]. Hypertension, 1995,26(3) :485-490.
  • 3Sakuragi S,Iwasaki J, Tokunaga N, et al. Aortic stiffness is an independent predictor of left ventricular function in patients with coronary heart disease[J]. Cardiology, 2005, 103(2) :107-112.
  • 4van Popele NM, Mattace-Raso FU, Vliegenthart R, et al. Aortic stiffness is associated with atherosclerosis of the coronary arteries in older adults:the Rotterdam study[J]. J Hypertens,2006,24(12):2371-2378,.
  • 5Willum-Hansen T, Staessen JA, Torp Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population[J]. Circulation,2006,113(5) :664-670.
  • 6刘泽林.血栓性疾病的诊断与治疗[M].北京:人民卫生出版社,2000.149-225.
  • 7杨成明,王旭开,曾春雨,王红勇,刘光耀,方玉强,傅春江,石伟彬,张晔.代谢综合征患者冠状动脉病变特点及相关危险因素的探讨[J].重庆医学,2008,37(6):588-589. 被引量:4
  • 8Bing H, Wang J, Zhang C, et al, Positive correlation he tween in vivo oxidized LDL and LDL immune complexes[J]. Clin Biochem, 2004,37 (1) : 72-79.
  • 9Rifai N, Ridker PM. High sensitivity C-reaction protein., a novel and promising maker of coronary heart disease[J]. Clin Chem,2001,47(3) :403-407.
  • 10董解菊,王秀丽,邵丽丽,尹智平.冠心病心功能不全患者高敏C反应蛋白变化[J].重庆医学,2004,33(11):1705-1706. 被引量:8

二级参考文献14

  • 1Ross R. Atherosclerosis-an inflammatory disease [J]. N Engl J Med,1999,340:115
  • 2Ledue TB, Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls[J]. Clin Chem Lab Med, 2001,39(11):1171
  • 3Whicher J, Rifai N, Biasucci LM. Markers of the acute phase response in cardiovascular disease: an update[J]. Clin Chem Lab Med, 2001,39(11):1054
  • 4Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease[J]. Clin Chem, 2001,47(3):403
  • 5Mehta J L,Saldeen T G,Rand K.Interaction role of infection,inflammation and traditional risk factors in atherosclerosis and coronary artery disease[J].J Am Cardiol,1998,31:1217
  • 6Lakka HM, I.aaksonen DE, I.akka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle aged men[J]. JAMA, 2002,288(12): 2709.
  • 7Chinali M, Devereux RB, Howard BV, et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study)[J]. Am J Cardiol,2004,93(1) :40.
  • 8Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome[J]. Diabetes Care, 2001,24 ( 5 ) : 683.
  • 9Solymoss BC, Bourassa MG, I.esperance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity[J]. Am J Cardiol, 2004,93(2):159.
  • 10Expert panel on detection, evaluation ,and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP)[J].JAMA, 2001,285 (19):2486.

共引文献16

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部